PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 25, 2026Cell & Bioscience1 citationsOpen Access

Regulation of oncogenic C-terminal truncated p53β protein isoform expression by SRSF3–UPF1 splicing and surveillance axis

JJJiwon JeongDHDawon HongTPTae Young Park

Key Points

  • The study aims to understand how SRSF3 and UPF1 regulate the expression of p53β mRNA, a protein linked to oncogenesis.
  • Identified SRSF3 binding sites in p53 intron 9.
  • Examined the formation of the SRSF3-UPF1 complex during transcription.
  • Assessed the impact of SRSF3 depletion on p53β mRNA levels.
  • Analyzed the functional consequences of p53β isoform on cell behavior.
  • SRSF3 binding facilitates UPF1 recruitment, regulating p53β mRNA production.
  • Depleting SRSF3 increased levels of the oncogenic p53β isoform.
  • The truncated p53β isoform promotes cell migration and invasion, indicating oncogenic potential.

Abstract

Dysregulated expression of tumor suppressor genes can impair their functions, even promoting oncogenesis. Expression of p53β mRNA can be regulated by alternative splicing and RNA surveillance, otherwise translated to a C-terminal truncated p53 protein with a unique neoepitope. Here, we identified that p53 introns bear the binding sites for serine and arginine-rich splicing factor 3 (SRSF3). SRSF3 binding to p53 intron 9 facilitates upstream frameshift 1 (UPF1) recruitment and regulates production of p53β mRNA. We also demonstrated that this ternary ribonucleoprotein complex forms cotranscriptionally in chromatin. SRSF3 depletion disrupts SRSF3-UPF1 axis, elevating the levels of p53β mRNA encoding a C-terminal-truncated isoform. Intriguitly, p53β protein isoform lacks tumor-suppressive activity and promotes oncogenic epithelial–mesenchymal transition through enhanced cell migration and invasion. We define the coordinated roles of the splicing factor SRSF3 and the RNA surveillance factor UPF1 in regulating p53 mRNA isoform expression, thereby linking splicing fidelity with RNA surveillance during transcription. Our findings highlight the SRSF3-UPF1 axis for preventing oncogenic p53β protein isoform accumulation, offering a potential therapeutic target to restore p53 function and impede cancer progression.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Jeong et al. (2026) studied this question.

synapsesocial.com/papers/69c37be2b34aaaeb1a67eb20https://doi.org/10.1186/s13578-026-01556-5
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The SR protein family of splicing factors: master regulators of gene expression2008 · 1,146 citations
  2. 2RBPmap: a web server for mapping binding sites of RNA-binding proteins2014 · 641 citations
  3. 3Intron retention is a widespread mechanism of tumor-suppressor inactivation2015 · 360 citations
  4. 4Splicing factor SRSF3 represses translation of p21cip1/waf1 mRNA2022 · 11 citations
  5. 5SR Proteins: Binders, Regulators, and Connectors of RNA2017 · 291 citations